Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T17:19:52.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Updated metadata to reflect a newer version (v3.1.0) and more current dates (2025-09) while removing older metadata (v3.0.2, 2025-05). This signals an updated release cycle and recentness without clear changes to core content.
    Difference
    0.7%
    Check dated 2025-09-28T10:12:49.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:17:17.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T21:22:07.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new drug names such as pembrolizumab and lenvatinib. The revision number has also been updated to v3.0.0.
    Difference
    3%
    Check dated 2025-08-30T15:58:28.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:47:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.